Oval Medical Technologies, a medical device start-up based in the U.K., has raised another stack of cash and announced positive results for a trial that compares its novel autoinjector with two well-known devices already on the market. According to the company, several large drugmakers have shown "substantial interest" in working with Oval and are undertaking feasibility studies to assess using the company's technology for a variety of injectable drugs, Ben Fountain of Cabume reports. Story